✦ LIBER ✦

PG 5.03 Molecular mechanisms in gastric cancer: Basis for therapy?

✍ Scribed by R. Seruca

Book ID: 117661863
Publisher: Elsevier Science
Year: 2012
Tongue: English
Weight: 45 KB
Volume: 48
Category: Article
ISSN: 0959-8049
DOI: 10.1016/s0959-8049(12)70017-5

No coin nor oath required. For personal study only.

📜 SIMILAR VOLUMES

The molecular basis of chemoradiosensiti

The molecular basis of chemoradiosensitivity in rectal cancer:implications for personalized therapies

✍ Marian Grade; Hendrik A. Wolff; Jochen Gaedcke; B. Michael Ghadimi 📂 Article 📅 2012 🏛 Springer 🌐 English ⚖ 579 KB

Aberrant methylation ofp16predicts candi

Aberrant methylation ofp16predicts candidates for 5-fluorouracil-based adjuvant therapy in gastric cancer patients

✍ Mayumi Mitsuno; Yoshihiko Kitajima; Takao Ide; Kazuma Ohtaka; Masayuki Tanaka; S 📂 Article 📅 2007 🏛 Springer Japan 🌐 English ⚖ 175 KB

Limitations in Controlling Risk for Recu

Limitations in Controlling Risk for Recurrence After Curative Surgery for Advanced Gastric Cancer Are Now Well-Explained by Molecular-Based Mechanisms

✍ Dimitrios H. Roukos; Aggelos M. Kappas 📂 Article 📅 2001 🏛 Springer 🌐 English ⚖ 20 KB

Molecular basis for sensitivity and acqu

Molecular basis for sensitivity and acquired resistance to gefitinib in HER2-overexpressing human gastric cancer cell lines derived from liver metastasis

✍ Yokoyama, H; Ikehara, Y; Kodera, Y; Ikehara, S; Yatabe, Y; Mochizuki, Y; Koike, 📂 Article 📅 2006 🏛 Nature Publishing Group 🌐 English ⚖ 243 KB

Mechanism-based enhancement of molecular

Mechanism-based enhancement of molecular, cellular and stromal therapies by PDT in a 3D model for micrometastatic ovarian cancer

✍ I. Rizvi; J. Celli; S. Elrington; A. Abu-Yousif; C. Evans; B. Spring; A. Blanden 📂 Article 📅 2011 🏛 Elsevier Science 🌐 English ⚖ 94 KB

The role of Fas ligand and transforming

The role of Fas ligand and transforming growth factor β in tumor progression : Molecular mechanisms of immune privilege via Fas-mediated apoptosis and potential targets for cancer therapy

✍ Ryungsa Kim; Manabu Emi; Kazuaki Tanabe; Yoko Uchida; Tetsuya Toge 📂 Article 📅 2004 🏛 John Wiley and Sons 🌐 English ⚖ 206 KB

## Abstract Despite the fact that expression of Fas ligand (FasL) in cytotoxic T lymphocytes (CTLs) and in natural killer (NK) cells plays an important role in Fas‐mediated tumor killing, During tumor progression FasL‐expressing tumor cells are involved in __counterattacking__ to kill tumor‐infiltr